Skip to main content
. 2021 Jul 9;19(3):330–337. doi: 10.1176/appi.focus.20200041

TABLE 1.

Effects of treatment interventions on perimenopausal depressiona

Treatment Treatment class Effect
Desvenlafaxine SNRI Decreased depressive symptoms as monotherapy (46, 48)
Cognitive-behavioral therapy Psychotherapy Decreased depressive symptoms as monotherapy (46)
Escitalopram SSRI Decreased depressive symptoms as monotherapy (46, 49)
Transdermal estradiol (with and/or without progesterone, dependent on intact uterus) Hormone therapy Decreased depressive symptoms as monotherapy or adjunctive treatment (46, 49, 50)
Prevention of depressive symptoms as monotherapy (51)
Tibolone STEAR Decreased depressive symptoms as adjunctive treatment (52)
Vortioxetine Serotonin modulator Decreased depressive symptoms as monotherapy (53)
a

SNRI, serotonin-norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; STEAR, selective tissue estrogenic activity regulator.